2016, Number 2
<< Back Next >>
An Med Asoc Med Hosp ABC 2016; 61 (2)
Mononeuritis multiple as a neurologic manifestation of Borrelia burgdorferi infection
García TMG, Shkurovich BP, Collado CMÁ, Alfaro TCE
Language: Spanish
References: 14
Page: 150-155
PDF size: 315.56 Kb.
ABSTRACT
The infection for
Borrelia burgdorferi is a zoonosis, in which the spirochaetes can be transmitted to human beings only by the bite of infected ixodid ticks, the spirochaete is maintained at high levels in populations of field mice or birds, the likelihood of having it is dependent on geography, recreational habits of the patient, and season. It is a multisistemic disease it can affect central nervous system. Neurological manifestations often referred to as Lyme neuroborreliosis are reported in up to 12% of patients with Lyme disease. In Europe and the United States seroprevalencia is 1 to 27%. This has not been determined in Mexico yet. The most common of them are painful meningoradiculitis (Bannwarth syndrome) and lymphocytic meningitis. Other neurological manifestations infrequently are cranial neuritis, plexus neuritis and mononeuritis multiplex. In Mexico are few reports and series of cases published about Lyme neuroborreliosis, being a subdiagnosed disease in patients with neurological clinical manifestations.
REFERENCES
Pachner AR, Steiner I. Lyme neuroborreliosis: infection, immunity, and inflammation. Lancet Neurol. 2007; 6 (6): 544-552.
Koedel U, Fingerle V, Pfister HW. Lyme neuroborreliosis-epidemiology, diagnosis and management. Nat Rev Neurol. 2015; 11 (8): 446-456.
Hansen K, Crone C, Kristoferitsch W. Lyme neuroborreliosis. Handb Clin Neurol. 2013; 115: 559-575.
Mygland A, Skarpaas T, Ljøstad U. Chronic polyneuropathy and Lyme disease. Eur J Neurol. 2006; 13 (11): 1213-1235.
Latov N, Wu AT, Chin RL, Sander HW, Alaedini A, Brannagan TH 3rd. Neuropathy and cognitive impairment following vaccination with the OspA protein of Borrelia burgdorferi. J Peripher Nerv Syst. 2004; 9 (3): 165-167.
Skinner C, Flores M, Esquivel J, Salinas J, Salinas C, Rodríguez J et al. Evidencia de la enfermedad de Lyme en una población de alto riesgo del noreste de México. Medicina Universitaria. 2007; 9 (36): 105-111.
Ramesh G, Santana-Gould L, Inglis FM, England JD, Philipp MT. The Lyme disease spirochete Borrelia burgdorferi induces inflammation and apoptosis in cells from dorsal root ganglia. J Neuroinflammation. 2013; 10: 88.
Halperin JJ. Lyme disease: a multisystem infection that affects the nervous system. Continuum (Minneap Minn). 2012; 18 (6 Infectious Disease): 1338-1350.
Wormser GP, Dattwyler RJ, Shapiro ED, Halperin JJ, Steere AC, Klempner MS et al. The clinical assessment, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 2006; 43 (9):1089-1134.
Vallat JM, Sommer C, Magy L. Chronic inflammatory demyelinating polyradiculoneuropathy: diagnostic and therapeutic challenges for a treatable condition. Lancet Neurol. 2010; 9 (4): 402-412.
Dressler F, Whalen JA, Reinhardt BN, Steere AC. Western blotting in the serodiagnosis of Lyme disease. J Infect Dis. 1993; 167 (2): 392-400.
Halperin JJ, Luft BJ, Anand AK, Roque CT, Alvarez O, Volkman DJ et al. Lyme neuroborreliosis: central nervous system manifestations. Neurology. 1989; 39 (6): 753-759.
Dattwyler RJ, Luft BJ, Kunkel MJ, Finkel MF, Wormser GP, Rush TJ et al. Ceftriaxone compared with doxycycline for the treatment of acute disseminated Lyme disease. N Engl J Med. 1997; 337 (5): 289-294.
Berglund J, Stjernberg L, Ornstein K, Tykesson-Joelsson K, Walter H. 5-year follow-up study of patients with neuroborreliosis. Scand J Infect Dis. 2002; 34 (6): 421-425.